Triclabendazole
Egaten (triclabendazole) is a small molecule pharmaceutical. Triclabendazole was first approved as Egaten on 2019-02-13. It is used to treat fascioliasis in the USA.
| Trade Name | Egaten |
|---|---|
| Common Name | Triclabendazole |
| Indication | fascioliasis |
| Drug Class | Anthelmintics (tibendazole type) |
